Durable complete response in advanced pancreatic ductal adenocarcinoma following prolonged gemcitabine monotherapy and stereotactic body radiotherapy
Oncology in Clinical Practice · 15.01.2026 · 22
DOI: 10.5603/ocp.115116 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncology in Clinical Practice, online erschienen am 15.01.2026. Verfasst von Kazimierz Kukla und 5 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Kukla, K., Maj, P., Lis, A., Gorzelak-Magiera, A., Kabut, J., & Gisterek-Grocholska, I. (2026). Durable complete response in advanced pancreatic ductal adenocarcinoma following prolonged gemcitabine monotherapy and stereotactic body radiotherapy. Oncology in Clinical Practice, 22(0). https://doi.org/10.5603/ocp.115116
Vancouver
Kukla K, Maj P, Lis A, Gorzelak-Magiera A, Kabut J, Gisterek-Grocholska I. Durable complete response in advanced pancreatic ductal adenocarcinoma following prolonged gemcitabine monotherapy and stereotactic body radiotherapy. Oncology in Clinical Practice. 2026;22(0). doi:10.5603/ocp.115116
BibTeX
@article{Kukla2026,
author = {Kukla, Kazimierz and Maj, Patrycja and Lis, Anna and Gorzelak-Magiera, Anita and Kabut, Jacek and Gisterek-Grocholska, Iwona},
title = {Durable complete response in advanced pancreatic ductal adenocarcinoma following prolonged gemcitabine monotherapy and stereotactic body radiotherapy},
journal = {Oncology in Clinical Practice},
year = {2026},
volume = {22},
number = {0},
doi = {10.5603/ocp.115116}
}
EUVIMED